High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
Urologic Oncology: Seminars and Original Investigations | Dec 08, 2017
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy
Urologic Oncology: Seminars and Original Investigations | Dec 04, 2017